Results 191 to 200 of about 2,294,616 (302)

Increased MAP-1 and lectin complement activation capacity in Klinefelter syndrome.

J Clin Endocrinol Metab
Chang S, Just J, Skakkebæk A, Hasselholm EB, Nielsen C, Garred P, Gravholt CH, Münster AB, Palarasah Y.   +8 more
europepmc   +1 more source

Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosis. [PDF]

Front Immunol
Santarsiero D, Galbusera M, Gastoldi S, Bresin E, Piras R, Alberti M, Vivarelli M, Prandini S, Conti S, Zotta F, Schubart A, Benigni A, Remuzzi G, Noris M, Aiello S.   +14 more
europepmc   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio, Desiree Latella, Lilla Bonanno, Paulo Cezar Rocha dos Santos, Marcos Maldonado‐Díaz, Meir Plotnik, Rosaria De Luca, Angelo Quartarone, Rocco Salvatore Calabrò   +8 more
wiley   +1 more source

Complement activation in secondary thrombotic microangiopathies. [PDF]

Nephrol Dial Transplant
Morelle J, Caravaca-Fontan F, Fakhouri F, Frangou E, Bruchfeld A, Floege J, Mirioglu S, Moran SM, Steiger S, Stevens KI, Teng OYK, Aydin S, Java A, Timmermans SAMEG, Kronbichler A.   +14 more
europepmc   +1 more source

White Matter Hyperintensity Burden and Short‐Interval Change Associated With Sleep Apnoea in the UK Biobank

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng, Diego Z. Carvalho, Shahid Karim, Anwar Chahal, Virend K. Somers   +4 more
wiley   +1 more source

Yersinia enterocolitica O:3 Outer Membrane Vesicles as a Platform for Complement Activation. [PDF]

J Extracell Vesicles
Battaglino C, Bodnaruk I, Czyszczoń P, Skurnik M, Filip-Psurska B, Jarych D, Maciejewska A, Gadzinowski M, Malik K, Potocka I, Migdał P, Kruszakin R, Cedzyński M, Kasperkiewicz K, Lukasiewicz J, Świerzko AS.   +15 more
europepmc   +1 more source

Comprehensive Assessment of Arterial, Tissue, and Venous Collaterals for Evaluating the Infarct Growth Rate: The Multimodal Collateral Score

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...
Giorgio Busto, Umberto Pensato, Ilaria Casetta, Giorgio U. Marcello, Angelo Barra, Anna Poggesi, Edoardo Carlesi, Sara Mancini, Andrea Ginestroni, Vittorio Miele, Alessandro Padovani, Andrea Morotti, Enrico Fainardi   +12 more
wiley   +1 more source

Engineering Liposomes and Polymer Conjugates: A Platform for Mechanistic Complement Activation Studies and Controlled Release Applications. [PDF]

ACS Appl Mater Interfaces
Hoecherl K, Konrad J, Reiner C, Streif S, Spitzenberg C, Sommer C, Pauly D, Breunig M, Baeumner AJ.   +8 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Complement Activation as a Predictor of Postoperative Delirium in Elderly Spine Surgery Patients. [PDF]

Int J Mol Sci
Vogelgesang A, Wolf H, Strack S, Flöel A, Schroeder HWS, Müller J, Müller JU, Fleischmann A, Fleischmann R, Pauly D, Ruhnau J.   +10 more
europepmc   +1 more source